162 related articles for article (PubMed ID: 6467673)
1. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
[TBL] [Abstract][Full Text] [Related]
2. Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.
Sugino H; Mitani I; Koike M; Kodama T; Sokawa J; Sawai H; Ishibashi K; Itoh M; Watanabe S; Sokawa Y
J Clin Microbiol; 1986 Sep; 24(3):478-81. PubMed ID: 3760142
[TBL] [Abstract][Full Text] [Related]
3. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.
Schattner A; Wallach D; Merlin G; Hahn T; Levin S; Ramot B; Revel M
J Interferon Res; 1982; 2(3):355-61. PubMed ID: 6182252
[TBL] [Abstract][Full Text] [Related]
4. Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases.
Buffet-Janvresse C; Magard H; Robert N; Hovanessian AG
Ann Immunol (Paris); 1983; 134D(2):247-58. PubMed ID: 6197930
[TBL] [Abstract][Full Text] [Related]
5. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
Chousterman S; Chousterman M; Reinert P; Thang MN
Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.
Vojdani A; Lapp CW
Immunopharmacol Immunotoxicol; 1999 May; 21(2):175-202. PubMed ID: 10319275
[TBL] [Abstract][Full Text] [Related]
8. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
Merritt JA; Borden EC; Ball LA
J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
[TBL] [Abstract][Full Text] [Related]
9. Differentiating between bacterial and viral infection by measuring both C-reactive protein and 2'-5'-oligoadenylate synthetase as inflammatory markers.
Sasaki K; Fujita I; Hamasaki Y; Miyazaki S
J Infect Chemother; 2002 Mar; 8(1):76-80. PubMed ID: 11957124
[TBL] [Abstract][Full Text] [Related]
10. 2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatment.
Merritt JA; Meltzer DM; Ball LA; Borden EC
Prog Clin Biol Res; 1985; 202():423-30. PubMed ID: 3832076
[TBL] [Abstract][Full Text] [Related]
11. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
[TBL] [Abstract][Full Text] [Related]
12. Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma.
Buffet-Janvresse C; Hovanessian AG
Proc Soc Exp Biol Med; 1984 Feb; 175(2):169-75. PubMed ID: 6198652
[TBL] [Abstract][Full Text] [Related]
13. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
14. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
15. Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.
Schattner A; Merlin G; Shapira A; Revel M; Wallach D
J Interferon Res; 1982; 2(2):285-9. PubMed ID: 6181178
[TBL] [Abstract][Full Text] [Related]
16. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
17. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator?
Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA
J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines.
Gazitt Y; Ben-Bassat H; Wallach D; Revel M; Schattner A
Clin Immunol Immunopathol; 1984 Jan; 30(1):71-9. PubMed ID: 6607796
[TBL] [Abstract][Full Text] [Related]
19. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
Ohmann HB; Campos M; Griebel PJ; Babiuk LA
Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
[TBL] [Abstract][Full Text] [Related]
20. The interferon/2-5A synthetase system in primary preleukaemia patients.
Justesen J; Hokland P; Hokland M
Prog Clin Biol Res; 1985; 202():439-47. PubMed ID: 3868780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
